Effect of infant immunisation with meningococcus serogroup C-CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children

被引:11
作者
McVernon, J
MacLennan, J
Clutterbuck, E
Buttery, J
Moxon, ER
机构
[1] John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Headington OX20 1XN, Oxon, England
[2] Univ Oxford, Dept Zool, Oxford OX1 3PS, Oxon, England
[3] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
关键词
diphtheria; meningococcal vaccines; immunisation schedule;
D O I
10.1016/S0264-410X(03)00058-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The majority of Men C conjugate vaccines given in the UK use CRM197, a mutant diphtheria toxoid, as their protein carrier. We studied the effects of prior immunisation with Men C-CRM197 conjugate vaccine on immunity to diphtheria in 193 children before and after a booster dose of Men C at 4 years. Baseline diphtheria antibodies were higher in children given four previous doses of Men C (P < 0.0001) and tended to be higher following boosting in those who had received three or four doses. This enhanced immunity was not associated with increased reactogenicity. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2573 / 2579
页数:7
相关论文
共 24 条
[1]   ADVERSE REACTIONS AND IMMUNOGENICITY IN ADULTS TO REGULAR AND INCREASED DOSAGE OF DIPHTHERIA VACCINE [J].
BJORKHOLM, B ;
GRANSTROM, M ;
WAHL, M ;
HEDSTROM, CE ;
HAGBERG, L .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (06) :637-640
[2]  
BRYETT KA, 1989, BRIT J CLIN PRACT, V43, P52
[3]   Successful control of epidemic diphtheria in the states of the former union of soviet socialist republics: Lessons learned [J].
Dittmann, S ;
Wharton, M ;
Vitek, C ;
Ciotti, M ;
Galazka, A ;
Guichard, S ;
Hardy, I ;
Kartoglu, U ;
Koyama, S ;
Kreysler, J ;
Martin, B ;
Mercer, D ;
Ronne, T ;
Roure, C ;
Steinglass, R ;
Strebel, P ;
Sutter, R ;
Trostle, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S10-S22
[4]   The sero-epidemiology of diphtheria in Western Europe [J].
Edmunds, WJ ;
Pebody, RG ;
Aggerback, H ;
Baron, S ;
Berbers, G ;
Conyn-Van Sphendonck, MAE ;
Hallander, HO ;
Olander, R ;
Maple, PAC ;
De Melker, HE ;
Olin, P ;
Fievret-Groyne, F ;
Rota, C ;
Salmaso, S ;
Tischer, A ;
Von-Hunolstein, C ;
Miller, E .
EPIDEMIOLOGY AND INFECTION, 2000, 125 (01) :113-125
[5]   A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants [J].
English, M ;
MacLennan, JM ;
Bowen-Morris, JM ;
Deeks, J ;
Boardman, M ;
Brown, K ;
Smith, S ;
Buttery, J ;
Clarke, J ;
Quataert, S ;
Lockhart, S ;
Moxon, ER .
VACCINE, 2000, 19 (9-10) :1232-1238
[6]   The changing epidemiology of diphtheria in the vaccine era [J].
Galazka, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S2-S9
[7]   The risk of vaccination - The importance of "negative'' studies [J].
Gellin, BG ;
Schaffner, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :372-373
[8]   Combination vaccines: Defining and addressing current safety concerns [J].
Halsey, NA .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S312-S318
[9]   The effect of reconstitution of an Haemophilus influenzae type b-tetanus toroid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine:: a five-year follow-up [J].
Hoppenbrouwers, K ;
Roelants, M ;
Ethevenaux, C ;
Vandermeulen, C ;
Knops, J ;
Desmyter, J .
VACCINE, 1999, 17 (20-21) :2588-2598
[10]   POTENTIAL ALTERATIONS IN IMMUNOGENICITY BY COMBINING OR SIMULTANEOUSLY ADMINISTERING VACCINE COMPONENTS [J].
INSEL, RA .
COMBINED VACCINES AND SIMULTANEOUS ADMINISTRATION: CURRENT ISSUES AND PERSPECTIVES, 1995, 754 :35-47